Abstract
While studies show that antibiotic treatment for uncomplicated diverticulitis seems to have no benefit, most experts advocate antimicrobial therapy for complicated diverticulitis. However, even for uncomplicated diverticulitis, most clinicians are very reluctant to withhold antibiotics. Biomarkers could help to guide antibiotic therapy as this approach has been shown to be effective for acute respiratory infections. In this diagnostic cohort study we evaluated whether procalcitonin could be a biomarker to distinguish complicated from uncomplicated cases of diverticulitis. Complicated diverticulitis was defined as having abscess formation or perforation diagnosed by abdominal computed tomography (CT) scan. In all patients with suspected diverticulitis, procalcitonin values were measured at admission and on day 2. These values were blinded for clinicians, and treatment was carried out according to the physician's judgement. Two groups (complicated vs uncomplicated diverticulitis) were defined. Patients who had received antibiotic treatment before admission were excluded. Difference in procalcitonin values was calculated for both groups using the Mann-Whitney test. Receiver operating characteristics (ROC) were calculated to determine cut-off values for procalcitonin according to the gold standard (abdominal CT scans). 115 patients were included for analysis. 35 patients (30%) suffered from complicated diverticulitis. The median procalcitonin value for uncomplicated diverticulitis was significantly lower compared to complicated diverticulitis (median 0.05, interquartile range [IQR] 0.05-0.06 ng/l vs median 0.13, IQR 0.05-0.23 ng/l; p <0.0001). In the ROC analysis, the sensitivity and specificity were 81% and 91% when the highest procalcitonin value (days 1 and 2) was considered, with a cut-off value of 0.1 ng/l. Procalcitonin was able to differentiate with a high sensitivity and specificity between complicated and uncomplicated cases of diverticulitis when combined with abdominal CT scans. As most clinicians still treat uncomplicated diverticulitis with antibiotics, procalcitonin could be an interesting parameter for guiding therapy and decreasing antibiotic usage. This should be further evaluated in randomised trials.
Highlights
There is growing evidence to promote the avoidance of antibiotic therapy in uncomplicated diverticulitis [1, 2], physicians often continue to prescribe antibiotics in any case of diverticulitis
The median procalcitonin value for uncomplicated diverticulitis was significantly lower compared to complicated diverticulitis
Procalcitonin was able to differentiate with a high sensitivity and specificity between complicated and uncomplicated cases of diverticulitis when combined with abdominal computed tomography (CT) scans
Summary
There is growing evidence to promote the avoidance of antibiotic therapy in uncomplicated diverticulitis [1, 2], physicians often continue to prescribe antibiotics in any case of diverticulitis. Availability of biomarkers would be useful to differentiate between complicated and uncomplicated diverticulitis and thereby guide antibiotic therapy. Procalcitonin has been identified as a biomarker in the diagnosis of bacterial infections in the setting of acute respiratory infections [4] and has been implemented in guidelines for antibiotic therapy in respective cases [4]. Procalcitonin failed to improve diagnosis and its sensitivity was even lower than C-reactive protein (CRP) [5]. Procalcitonin was able to identify more complicated cases of appendicitis [5]. Procalcitonin may be helpful early in the course of this heterogeneous disease to differentiate between bacterial infection and, e.g., post-operative inflammation [6]. The role of procalcitonin in sepsis remains controversial and its trend (persistently high values vs faster clearing kinetics) rather than isolated values seem to have a higher clinical relevance [7]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.